☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
GSK
GSK Reports the CHMP’s Positive Opinion of Menveo Vaccine Against Invasive Meningococcal Disease
September 24, 2024
GSK Reports Topline Results from the P-III Trial of Arexvy Co-Administered with Shingrix
September 19, 2024
GSK Reports the NDA Acceptance of Blenrep Combinations by the Japanese MHLW for R/R Multiple Myeloma
September 20, 2024
GSK’s Blenrep Combination Gains the NMPA’s Breakthrough Therapy Designation to Treat R/R Multiple Myeloma
September 13, 2024
GSK Reports Headline Data from P-II Study of Seasonal Influenza mRNA Vaccine
September 12, 2024
GSK Reports P-I/II Study Updates of GSK3943104 HSV Vaccine
September 11, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.